Cefalo, Chiara Maria Assunta
 Distribuzione geografica
Continente #
NA - Nord America 1.221
AS - Asia 961
EU - Europa 904
SA - Sud America 208
AF - Africa 22
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.323
Nazione #
US - Stati Uniti d'America 1.194
SG - Singapore 450
CN - Cina 261
BR - Brasile 187
IT - Italia 178
DE - Germania 157
SE - Svezia 146
FR - Francia 81
PL - Polonia 61
IE - Irlanda 58
GB - Regno Unito 57
VN - Vietnam 49
FI - Finlandia 41
IN - India 34
ID - Indonesia 33
UA - Ucraina 27
TR - Turchia 24
KR - Corea 20
RU - Federazione Russa 19
BE - Belgio 16
CA - Canada 14
SA - Arabia Saudita 14
AR - Argentina 13
BD - Bangladesh 12
AT - Austria 11
HK - Hong Kong 11
IR - Iran 11
NL - Olanda 11
ES - Italia 10
CH - Svizzera 9
MX - Messico 9
IQ - Iraq 7
ZA - Sudafrica 7
JP - Giappone 6
UZ - Uzbekistan 5
GR - Grecia 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
AZ - Azerbaigian 3
BG - Bulgaria 3
JM - Giamaica 3
LT - Lituania 3
MA - Marocco 3
OM - Oman 3
CI - Costa d'Avorio 2
CO - Colombia 2
DK - Danimarca 2
DZ - Algeria 2
PT - Portogallo 2
PY - Paraguay 2
RE - Reunion 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CL - Cile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
RO - Romania 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
VA - Santa Sede (Città del Vaticano) 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
Totale 3.323
Città #
Singapore 196
Chandler 178
Ashburn 132
Dublin 58
Warsaw 57
Beijing 51
Hefei 51
Rome 50
Los Angeles 47
Chicago 46
Fairfield 41
New York 40
Wilmington 38
Jakarta 33
San Mateo 32
Helsinki 26
Seattle 23
Ann Arbor 21
Ho Chi Minh City 21
Milan 21
Munich 20
São Paulo 20
Seoul 19
The Dalles 19
Dallas 18
Houston 17
Bremen 16
Brussels 16
Kent 15
Marseille 15
Boston 13
Frankfurt am Main 13
Hanoi 13
Basking Ridge 12
Busto Arsizio 12
Cattolica 12
Falls Church 12
Nanjing 12
Nuremberg 12
Princeton 12
Moscow 11
Pune 11
Santa Clara 11
Hong Kong 10
Augusta 9
Cambridge 9
Dearborn 9
Izmir 9
Woodbridge 9
Jacksonville 8
Norwalk 8
Riyadh 8
Toronto 8
Vienna 8
Zurich 8
Atlanta 7
Düsseldorf 7
Hangzhou 7
London 7
Tianjin 7
Amsterdam 6
Bologna 6
Brooklyn 6
Dong Ket 6
Tokyo 6
Turku 6
Andover 5
Belo Horizonte 5
Brasília 5
Charlotte 5
Lappeenranta 5
Lauterbourg 5
Manaus 5
Nürnberg 5
Phoenix 5
Redwood City 5
Rio de Janeiro 5
Stockholm 5
Tabriz 5
Barcelona 4
Cape Town 4
Chennai 4
Denver 4
Guarulhos 4
Jeddah 4
Kish 4
Lancaster 4
Lawrence 4
Mountain View 4
North Bergen 4
Orem 4
Recife 4
Tashkent 4
Albany 3
Baghdad 3
Baku 3
Bexley 3
Buffalo 3
Edinburgh 3
Guangzhou 3
Totale 1.809
Nome #
Sotagliflozin, the first dual SGLT inhibitor: Current outlook and perspectives 11 Medical and Health Sciences 1103 Clinical Sciences 253
β-Cell Glucose Sensitivity Is Linked to Insulin/Glucagon Bihormonal Cells in Nondiabetic Humans. 172
Metabolic consequences of the occlusion of the main pancreatic duct with acrylic glue after pancreaticoduodenectomy 167
β-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity 154
Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional β cells in predicting diabetes 152
Hypovitaminosis D Is Associated with Liver Insulin Resistance in Obese Subjects 151
Endocrine and Metabolic Insights from Pancreatic Surgery 148
Increased B-cell workload modulates proinsulin-to-insulin ratio in humans 137
Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: Evidence to date 134
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 130
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 122
Prediabetes: how pathophysiology drives potential intervention on a subclinical disease with feared clinical consequences 121
Noradrenergic fibers are associated with beta-cell dedifferentiation and impaired beta-cell function in humans 120
β α-Cell glucose sensitivity is linked to insulin/glucagon bihormonal cells in nondiabetic humans 116
First-phase insulin secretion: can its evaluation direct therapeutic approaches? 114
Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features 103
The Interplay between Immune System and Microbiota in Diabetes 98
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes 96
Erythrocyte membrane fluidity: A novel biomarker of residual cardiovascular risk in type 2 diabetes 93
A systematic comparison of protocols for recovery of high-quality rna from human islets extracted by laser capture microdissection 92
PREVALENCE OF LIVER STEATOSIS AND METABOLIC SYNDROME IN PATIENTS WITH PSORIASIS 77
ELF TEST IS A RELIABLE NON INVASIVE TEST FOR FIBROSIS IN NAFLD SUBJECTS 66
Genetic and environmental factors responsible for oxidative stress in now alcoholic fatty liver disease (NAFLD) 63
PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND METABOLIC SYNDROME IN PATIENTS WITH PSORIASIS 62
Effects of PCSK9 inhibition on glucose metabolism and β-cell function in humans: a pilot study 61
A PROPOSAL MODEL FOR THE NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) 60
SERUM SODIUM IS A PREDICTOR OF SURVIVAL FOR "INTERMEDIATE HCC" TREATED WITH TRANSARTERIAL CHEMIOEMBOLIZATION (TACE) 59
Steatohepatitis and type 2 diabetes mellitus are influenced by genetic susceptibility to increased intestinal permeability in patients with non-alcoholic fatty liver disease 56
Pilot Study on the Role of Multidisciplinary Approach in Risk Reduction of Risk of Non- alcoholic Fatty Liver in Subjects with Eating Disorders 51
Liver functional reserve and survival after sunitinib therapy in cirrhotic patients with advanced hepatocellular carcinoma 45
THE 15 AND 30 MINUTES SAMPLING OF 13C-BREATH TESTING ARE ABLE TO PREDICT SEVERE HEPATIC FIBROSIS AND SEVERITY OF LIVER DISEASE 44
HEPARANASE IN NASH: IS IT AN USEFUL MARKER OF FIBROGENESIS? 42
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 30
Totale 3.389
Categoria #
all - tutte 16.859
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.859


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021120 0 0 0 0 0 10 12 12 18 11 43 14
2021/2022334 39 9 22 24 19 13 31 57 13 21 38 48
2022/2023586 56 48 51 90 28 77 27 41 54 41 40 33
2023/2024369 19 84 15 29 25 44 35 21 10 32 19 36
2024/2025780 15 22 67 26 43 27 27 48 95 86 175 149
2025/2026840 243 57 107 178 242 13 0 0 0 0 0 0
Totale 3.389